Augmentin and Clavulin are trade names for a combination of amoxicillin and clavulanic acid. The International Nonproprietary Name for this combination is amoxicillin/clavulanic acid, and co-amoxiclav the British Approved Name.
- TRADE NAMES: A-Gram; Acimox; Almodan; Amodex; Amoxil (GSK); Apo-Amoxi; Augmentin (GSK); Clamoxyl; Clavulin (GSK); Eupen; Fisamox; Lin-Amnox; Novamoxin; Nu-Amoxi; Prevpac (TAP); Pro-Amox; Trimox (Bristol-Myers Squibb)
- INDICATIONS: Infections of the respiratory tract, skin and urinary tract
- SYNONYM: amoxycillin
- CLASS: Antibiotic, Antibiotic; beta-lactam, Antibiotic; penicillin, Antimicrobial
- HALF-LIFE: 0.7–1.4 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Allopurinol, Bromelain, Chloramphenicol, Demeclocycline, Doxycycline, Erythromycin, Imipenem/Cilastatin, Methotrexate, Minocycline, Omeprazole, Oxytetracycline, Sulfonamides, Tetracycline
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of amoxicillin in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 11/17/2024
